Skip to main content

Table 1 :

From: Quality of Life (QOL) improvement following catheter-based autologous bone marrow mononuclear cell transplantation (ABM-MCT)

 

Baseline

8 weeks

P

24 weeks

P

Canadian Cardiovascular Society class

2.64 ± 0.84

1.28 ± 0.61

0.0001

1.44 ± 0.5

0.003

Ejection fraction

30 ± 5

35 ± 8

0.029

32.4 ± 6

0.04

End systolic volume

147 ± 53

123 ± 48

0.02

139 ± 49

0.01

VO2max

17.96 ± 8.78

23.4 ± 8

0.01

24.4 ± 8

0.05

Total reversibility defect

15 ± 14

4.5 ± 10

0.02